SEC Form 4 · accession 0001209191-15-027955
TREVENA INC · TRVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Soergel
Officer — Sr. VP,Clinical Dev. & CMO
Period of report
Mar 17, 2015
Accepted (ET)
Mar 19, 2015 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001429560
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $6.79 | Mar 17, 2015 | A | 87,500 | A | — | Mar 17, 2025 | Common Stock | 87,500 | 87,500 | D |
Explanation of responses
- F1The option shall vest and become exercisable with respect to one-fourth of the total number of shares subject to the option on each of March 17, 2016, March 17, 2017, March 17, 2018 and March 17, 2019, subject to the reporting person's Continuous Service (as defined in the Trevena, Inc. 2013 Equity Incentive Plan, as amended) as of each such vesting date.